Invacare Corporation Receives Multiple Awards for Outstanding Product from Mobility Management Magazine
27 Jul 2022
ELYRIA, Ohio--(BUSINESS WIRE)-- Invacare Corporation (“Invacare”) (NYSE: IVC), a leading manufacturer and distributor of medical equipment used in non-acute care settings, has been recognized by Mobility Management magazine in multiple product categories for outstanding product and technology development in complex rehab.
“We are pleased to once again be recognized for our industry-leading mobility products which deliver important user benefits. These awards are a testament to our culture of innovation and reflect our commitment to keeping our customers and end users needs at the forefront of our design process,” said Matt Monaghan, chairman, president and chief executive officer.
Invacare’s leading mobility and seating products span a breadth of categories, with awards in the following categories:
Wheelchairs, Power: Group 3, multiple power:
Invacare® AVIVA® Storm® RX Rear-Wheel Drive Power Wheelchair with Ultra Low Maxx
Wheelchairs, Power: Group 3, single power:
Invacare® AVIVA® Storm® RX Rear-Wheel Drive Power Wheelchair with Ultra Low Maxx
Power Assist Systems:
Alber™ e-motion™M25 Power Assist for Wheelchairs
Accessories, Wheelchair:
Motion Concepts Maxx Resolve Swing-Away Joystick Mount
Positioning, Head:
Motion Concepts Matrx® Loxx headrest hardware
Seat Cushions, skin protection & positioning/E2607-2608
Motion Concepts Matrx® PSP HD (Posture Seat Polymer) Cushion
A complete list of winners can be found in the Aug/Sep 2022 issue of Mobility Management magazine and featured on the brand’s website
About Invacare Corporation
Invacare Corporation (NYSE:IVC)(“Invacare” or the “company”) is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest, and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe, and Asia/Pacific. For more information about the company and its products, visit Invacare's website at .
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.